DK1421086T3 - 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet - Google Patents

2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet

Info

Publication number
DK1421086T3
DK1421086T3 DK02756528T DK02756528T DK1421086T3 DK 1421086 T3 DK1421086 T3 DK 1421086T3 DK 02756528 T DK02756528 T DK 02756528T DK 02756528 T DK02756528 T DK 02756528T DK 1421086 T3 DK1421086 T3 DK 1421086T3
Authority
DK
Denmark
Prior art keywords
diaza
cyclopenta
oxa
aminomethyl
tetrahydro
Prior art date
Application number
DK02756528T
Other languages
Danish (da)
English (en)
Inventor
Richard Eric Mewshaw
Rulin Zhao
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1421086T3 publication Critical patent/DK1421086T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK02756528T 2001-07-20 2002-07-19 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet DK1421086T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30693101P 2001-07-20 2001-07-20

Publications (1)

Publication Number Publication Date
DK1421086T3 true DK1421086T3 (da) 2006-12-11

Family

ID=23187510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02756528T DK1421086T3 (da) 2001-07-20 2002-07-19 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet

Country Status (12)

Country Link
US (1) US6541502B1 (pt)
EP (1) EP1421086B1 (pt)
JP (1) JP2004537556A (pt)
CN (1) CN100369916C (pt)
AT (1) ATE338046T1 (pt)
BR (1) BR0211207A (pt)
CA (1) CA2454543A1 (pt)
DE (1) DE60214397T2 (pt)
DK (1) DK1421086T3 (pt)
ES (1) ES2271314T3 (pt)
MX (1) MXPA04000581A (pt)
WO (1) WO2003008419A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201412727A (zh) * 2012-08-24 2014-04-01 Daiichi Sankyo Co Ltd 具有鏈狀側鏈之色酮衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
US5756532A (en) 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
AR004523A1 (es) 1995-11-06 1998-12-16 American Home Prod 2-(AMINOMETIL)-3,4,7,9-TETRAHIDRO-2H-PIRANO-[2,3e] INDOL-8-ONAS Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US5750556A (en) 1996-10-30 1998-05-12 American Home Products Corporation 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives
KR20000071129A (ko) * 1997-02-18 2000-11-25 이곤 이 버그 4-아미노알콕시-1ｈ-벤즈이미다졸 유도체, 이의 제조방법 및도파민 자가수용체(ｄ2) 효능제로서의 이의 용도

Also Published As

Publication number Publication date
CN1555377A (zh) 2004-12-15
BR0211207A (pt) 2004-07-13
ATE338046T1 (de) 2006-09-15
WO2003008419A1 (en) 2003-01-30
EP1421086A1 (en) 2004-05-26
DE60214397D1 (en) 2006-10-12
MXPA04000581A (es) 2004-04-20
ES2271314T3 (es) 2007-04-16
JP2004537556A (ja) 2004-12-16
DE60214397T2 (de) 2007-10-11
CN100369916C (zh) 2008-02-20
US6541502B1 (en) 2003-04-01
CA2454543A1 (en) 2003-01-30
EP1421086B1 (en) 2006-08-30

Similar Documents

Publication Publication Date Title
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
HK1086256A1 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
EP1764092A3 (en) Selecting compounds for treatment of Alzheimer's disease
EA200600203A1 (ru) Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20052908L (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
NO20062629L (no) Oksazolderivater av tetrackliner
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BRPI0409276A (pt) derivados de piperazina inibidores de renina
DE60112960D1 (de) Kondensierte pyridoindolderivate
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
ATE515266T1 (de) 2-(amino-3,4-dioxo-1-cyclobuten-1- yl)aminoalkylsäure-derivate für die schmerzbehandlung
SE0200198D0 (sv) New use
DK1421086T3 (da) 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
AU2003250465A1 (en) 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors
DK1409490T3 (da) 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
UY27560A1 (es) Compuestos hexaciclicos-
DK1487802T3 (da) 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer
NO20025101D0 (no) Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet
DK1553938T3 (da) Anvendelse af epothilonderivater til behandling af hyperparathyroidisme